News

Heart device trial gets $16.5 million funding – Salt Lake City, Utah company, Coherex Medical to test stent for migraine relief.

August 21, 2009 /

MATR Sponsor (view all)


The MDT Disadvantaged Business Enterprise (DBE) Program encourages and supports the participation of companies owned and controlled by socially and economically disadvantaged individuals in transportation contracts.

A Salt Lake City company has received $16.5 million in venture capital to begin clinical trials on a medical device that repairs a heart defect — a procedure that also could prove to be a significant breakthrough in treating migraine headaches.

Coherex Medical http://www.coherex.com/ said it hopes to announce when clinical trials will begin in the United States by the end of the year, but it already is selling its device in most of Europe after getting approvals there.

By Tom Harvey

The Salt Lake Tribune

http://www.sltrib.com/business/ci_13171861

MATR Supporters (view all)


Montana Bioscience Cluster Initiative - Collaborative program design and execution and integrated programs fostering innovation, technology commercialization, entrepreneurship and sustainable small businesses

For over 25 years, Montana World Trade Center® has served Montana as a trusted business adviser.

Big Sky Commerce is an integrated provider of merchant credit card transaction processing services, check processing services, Internet payment gateways, related software application products and value-added services.
Posted in:

Sorry, we couldn't find any posts. Please try a different search.

Leave a Comment

You must be logged in to post a comment.